EX-23.1 7 notv-20230930xex231.htm EX-23.1
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1)Registration Statement (Form S-3 No. 333-253309) of Inotiv, Inc.,
(2)Registration Statement (Form S-3 No. 333-266962) of Inotiv, Inc.,
(3)Registration Statement (Form S-8 No. 333-153734) pertaining to the Non-Qualified Stock Option Agreement and Employee Incentive Stock Option Agreement from the 2008 Stock Option Plan,
(4)Registration Statement (Form S-8 No. 333-228747) pertaining to the 2008 Stock Option Plan as Amended and Restated in the form of the Amended and Restated Bioanalytical Systems, Inc. Equity Incentive Plan,
(5)Registration Statement (Form S-8 No. 333-237580) pertaining to the Amended and Restated Bioanalytical Systems, Inc. 2018 Equity Incentive Plan,
(6)Registration Statement (Form S-8 No. 333-261025) pertaining to the Amended and Restated Inotiv, Inc. 2018 Equity Incentive Plan, and
(7)Registration Statement (Form S-8 No. 333-261038) pertaining to the Envigo RMS Holding Corp. Equity Incentive Plan.
of our reports dated December 11, 2023, with respect to the consolidated financial statements of Inotiv, Inc., and the effectiveness of internal control over financial reporting of Inotiv, Inc. included in this Annual Report (Form 10-K) of Inotiv, Inc., for the year ended September 30, 2023.

/s/ Ernst & Young LLP |
Indianapolis, IN |
December 11, 2023 |